| |
|
|
|
|
|
|
|||
|
Blood, 1 December 2007, Vol. 110, No. 12, pp. 3853-3861. Prepublished online as a Blood First Edition Paper on August 16, 2007; DOI 10.1182/blood-2007-03-079582.
HEMATOPOIESIS Cdc42 critically regulates the balance between myelopoiesis and erythropoiesisDivisions of1 Experimental Hematology and 2 Pathology, Children's Hospital Medical Center, Cincinnati; and 3 Molecular Developmental Biology Graduate Program, University of Cincinnati, OH
The Rho GTPase Cdc42 regulates adhesion, migration, and homing, as well as cell cycle progression, of hematopoietic stem cells, but its role in multilineage blood development remains unclear. We report here that inducible deletion of cdc42 in cdc42-floxed mouse bone marrow by the interferon-responsive, Mx1-Cre–mediated excision led to myeloid and erythroid developmental defects. Cdc42 deletion affected the number of early myeloid progenitors while suppressing erythroid differentiation. Cdc42-deficient mice developed a fatal myeloproliferative disorder manifested by significant leukocytosis with neutrophilia, myeloid hyperproliferation, and myeloid cell infiltration into distal organs. Concurrently, Cdc42 deficiency caused anemia and splenomegaly accompanied with decreased bone marrow erythroid burst-forming units (BFU-Es) and colony-forming units-erythroid (CFU-Es) activities and reduced immature erythroid progenitors, suggesting that Cdc42 deficiency causes a block in the early stage of erythropoiesis. Cdc42 activity is responsive to stimulation by SCF, IL3, SDF-1
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||
| Copyright © 2007 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||||